Showing 5301-5310 of 5689 results for "".
- Biogen Completes Acquisition of Nightstar Therapeutics for Approximately $800 Millionhttps://modernod.com/news/biogen-completes-acquisition-of-nightstar-therapeutics-for-approximately-800-million/2476641/Biogen announced that it has completed its acquisition of gene therapy company Nightstar Therapeutics, which is focused on adeno-associated virus (AAV) treatments for inherited retinal disorders. As a result of the acquisition, Biogen now has added two mid- to late-stage clinical ass
- EyePoint Pharmaceuticals Names New Members of Executive Leadership Teamhttps://modernod.com/news/eyepoint-pharmaceuticals-names-new-members-of-executive-leadership-team/2476642/EyePoint Pharmaceuticals announced the appointment of Scott Jones as Chief Commercial Officer and Said Saim, PhD, as Chief Technology Officer. Mr. Jones will be responsible for the commercialization of Dexycu (dexamethasone intraocular suspension) 9% for the treatment of postoperative inflammatio
- Draper James and VSP Eyes of Hope Commit Nearly $4 Million to Fund Eye Care and Eyewear in Support of Young Womenhttps://modernod.com/news/draper-james-and-vsp-eyes-of-hope-commit-nearly-4-million-to-fund-eye-care-and-eyewear-in-support-of-young-women/2476637/More women than men are at risk for vision loss from eye diseases like glaucoma and macular degeneration. To help ensure more women have access to critical eye care, Draper James, the Southern-inspired lifestyle brand founded by Reese Witherspoon, announced a partne
- More Elderly Americans Dying From Fallshttps://modernod.com/news/more-elderly-americans-dying-from-falls/2476634/Death rates from falls are rising among elderly Americans and climbing fastest among seniors in their 90s, a US study suggests. Among all adults 75 and older, mortality from falls climbed 5.1% from 2000 to 2016, researchers report in JAMA. Death rates from falls rose the most—6.4%—among
- Pioneering Ophthalmologist Patricia Bath, MD, Dies at 76https://modernod.com/news/pioneering-ophthalmologist-patricia-bath-md-dies-at-76/2476632/Patricia E. Bath, MD, an ophthalmologist who took a special interest in combating preventable blindness in underserved populations and became the first black female doctor to patent a medical invention, a laser device for treating cataracts, died at the age of 76, acc
- Allegro Ophthalmics Announces Positive Topline Results of Phase 2 Study Evaluating Risuteganib in Patients with Intermediate Dry AMDhttps://modernod.com/news/allegro-ophthalmics-announces-positive-topline-results-of-phase-2-study-evaluating-risuteganib-in-patients-with-intermediate-dry-amd/2476627/Allegro Ophthalmics announced positive topline results of its phase 2 study of risuteganib (Luminate) for the treatment of intermediate dry age-related macular degeneration (AMD). The clinical trial met its primary endpoint with 48 percent of patients in the risuteganib arm gaining ≥ 8 letters of
- Re-Vana Therapeutics Names International Experts to Inaugural Scientific Advisory Boardhttps://modernod.com/news/re-vana-therapeutics-names-international-experts-to-inaugural-scientific-advisory-board/2476628/Re-Vana Therapeutics announced the formation of its new Scientific Advisory Board (SAB). The newly appointed SAB will strategically advise and support Re-Vana as it develops innovative therapies for a broad range of ophthalmic indications, including wet age-related macular degeneration (AMD), dia
- Precision Medicine to Prevent Glaucoma-Related Blindnesshttps://modernod.com/news/precision-medicine-to-prevent-glaucoma-related-blindness/2476617/Approximately 10% of patients become blind despite using evidence-based guidelines developed from clinical trials and epidemiology studies. Our purpose is to review opportunities to decrease glaucoma-related blindness using the emerging principles of precision medicine.
- Study: 3D Printed Artificial Corneas Similar to Human Oneshttps://modernod.com/news/study-3d-printed-artificial-corneas-similar-to-human-ones/2476615/When a person has a severely damaged cornea, a corneal transplant is required. However, there are 2,000 patients waiting for the cornea donation in the country as of 2018, and they wait for 6 or more years on average for the donation. For this reason, many scientists have put their efforts in dev
- Central Retinal Vein Occlusion Rarely Complicates Ulcerative Colitishttps://modernod.com/news/central-retinal-vein-occlusion-rarely-complicates-ulcerative-colitis/2476609/Central retinal vein occlusion (CRVO) can rarely complicate the course of inflammatory bowel disease (IBD), according to a case series, as reported by Reuters. As many as 11.8% of patients with IBD can develop ophthalmological compl